Indian Expert Panel Recommends Emergency Use Approval for Covaxin in 2 to 18 Age Group
An expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain conditions, sources said on Tuesday.